InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: rollup post# 33546

Sunday, 01/10/2021 7:36:44 PM

Sunday, January 10, 2021 7:36:44 PM

Post# of 44690
RLF-100 will show Good Data when the results are shown. We know the trending from the 102 data. Highly probably the Best Severe COVID-19 Treatment. With the added wide spectrum of RLF-100 uses the Patents present.

A possible R/S Reasoning at this point will possibly be Joining the Merger with BRPA and NRX.

RLF-100 will be the ""JEWEL"" if there is good Data. NRX does not own the Patent rights to RLF-100, WE do. NRX-101 isn't worth the deal alone and BRPA has 'investigating suits' now due to questions of their deal value for NRX.
The math right now is easy @.5 and 1 for 20 R/S. RLF shareholders will own 130M - $10 shares out of about 225M shares of ?NRLXP? in the end.*.
(WAG numbers)
GEM and insiders control any Vote @ RLF and GEM can consolidate their investments. They hold the BALL, we are just on the Ride, IMHFO.

""NRLXP"" will hit The Market right as "SUCCESSFUL" Data from the current RLF/NRX Clinical Trial is released.
The US and WORLD COVID-19 issues continue to worsen and Vaccines will need time for sufficient inoculations at a 70% + target.

A R/S for US WILL BE A GOOD THING.

IMO, IF there is enough "Enthusiasm and PUMP" due to Very Good Data AND the companies HAVE been working Logistics/Sales AND there is Increased Demand, it may be needed to increase the OS with a Forward split, say 2++ for 1...

Possibly pretty good #$ as soon as April, possibly. These kinds of possibilities are why I play...IMHFO...GLTA...



* 600M shares from Dec @ 1/20 is 30M to NRX/BRPA.